A Phase Ⅱa Study of the Safety, Tolerability and Efficacy of BD111 in Herpes Simplex Virus Type I Stromal Keratitis

计划入组 40 人 · 首次发布于 2024 年 6 月 25 日

HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1, HSV-2 Co-infected Men.

计划入组 20 人 · 首次发布于 2006 年 9 月 21 日

Valacyclovir vs. Acyclovir as HSV-2 Suppressive Therapy: Effect on Plasma HIV-1 Levels Among HIV-1/HSV-2 Co-infected Persons

计划入组 32 人 · 首次发布于 2009 年 12 月 4 日

HSV-1-targeted CRISPR/Cas9 gene therapy (AAV vector, HSV-1-induced keratitis)

anti-HSV-1 agent

RVx-101 HSV-1

NHI-1

United States

Xi'an No.1 Hospital

China

ALPHA-1 FOUNDATION, INC.

United States

Excision BioTherapeutics Showcases Promising CRISPR-Based Therapies for HBV and HSV at ASGCT 2025

Krystal Biotech Receives FDA Platform Technology Designation for HSV-1 Gene Therapy Vector

Theralase's Ruvidar® Shows Complete Healing of HSV-1 Lesions in Preclinical Study